MKI67 and lung cancer: While ERL + NC miR treatment was similar to ERL treatment alone, ERL + miR-708-5p further suppressed lung cancer cell proliferation, with 51% of combinatory treated A549 cells were Ki-67+ (Figure 4, p < 0.0001, n ≥ 3).